175 related articles for article (PubMed ID: 36301719)
21. Silibinin Capsules improves high fat diet-induced nonalcoholic fatty liver disease in hamsters through modifying hepatic de novo lipogenesis and fatty acid oxidation.
Cui CX; Deng JN; Yan L; Liu YY; Fan JY; Mu HN; Sun HY; Wang YH; Han JY
J Ethnopharmacol; 2017 Aug; 208():24-35. PubMed ID: 28648927
[TBL] [Abstract][Full Text] [Related]
22. Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation.
Weng SW; Wu JC; Shen FC; Chang YH; Su YJ; Lian WS; Tai MH; Su CH; Chuang JH; Lin TK; Liou CW; Chu TH; Kao YH; Wang FS; Wang PW
Diabetologia; 2023 May; 66(5):913-930. PubMed ID: 36692509
[TBL] [Abstract][Full Text] [Related]
23. A Comparison of Primary Human Hepatocytes and Hepatoma Cell Lines to Model the Effects of Fatty Acids, Fructose and Glucose on Liver Cell Lipid Accumulation.
Huggett ZJ; Smith A; De Vivo N; Gomez D; Jethwa P; Brameld JM; Bennett A; Salter AM
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615698
[TBL] [Abstract][Full Text] [Related]
24. Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD.
Latorre J; Moreno-Navarrete JM; Mercader JM; Sabater M; Rovira Ò; Gironès J; Ricart W; Fernández-Real JM; Ortega FJ
Int J Obes (Lond); 2017 Apr; 41(4):620-630. PubMed ID: 28119530
[TBL] [Abstract][Full Text] [Related]
25. Targeted metabolomics profiles serum fatty acids by HFD induced non-alcoholic fatty liver in mice based on GC-MS.
Yan X; Li L; Liu P; Xu J; Wang Z; Ding L; Yang L
J Pharm Biomed Anal; 2022 Mar; 211():114620. PubMed ID: 35124446
[TBL] [Abstract][Full Text] [Related]
26. Intracellular lipid content is a key intrinsic determinant for hepatocyte viability and metabolic and inflammatory states in mice.
Sheng L; Jiang B; Rui L
Am J Physiol Endocrinol Metab; 2013 Nov; 305(9):E1115-23. PubMed ID: 23982157
[TBL] [Abstract][Full Text] [Related]
27. In vitro cellular models of human hepatic fatty acid metabolism: differences between Huh7 and HepG2 cell lines in human and fetal bovine culturing serum.
Gunn PJ; Green CJ; Pramfalk C; Hodson L
Physiol Rep; 2017 Dec; 5(24):. PubMed ID: 29263118
[TBL] [Abstract][Full Text] [Related]
28. Ferulic Acid Prevents Nonalcoholic Fatty Liver Disease by Promoting Fatty Acid Oxidation and Energy Expenditure in C57BL/6 Mice Fed a High-Fat Diet.
Luo Z; Li M; Yang Q; Zhang Y; Liu F; Gong L; Han L; Wang M
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745260
[TBL] [Abstract][Full Text] [Related]
29. Mapping the triglyceride distribution in NAFLD human liver by MALDI imaging mass spectrometry reveals molecular differences in micro and macro steatosis.
Alamri H; Patterson NH; Yang E; Zoroquiain P; Lazaris A; Chaurand P; Metrakos P
Anal Bioanal Chem; 2019 Feb; 411(4):885-894. PubMed ID: 30515538
[TBL] [Abstract][Full Text] [Related]
30. The PDE5 inhibitor udenafil ameliorates nonalcoholic fatty liver disease by improving mitochondrial function.
Yu HM; Chung HK; Park KS
Biochem Biophys Res Commun; 2021 Jun; 558():57-63. PubMed ID: 33895552
[TBL] [Abstract][Full Text] [Related]
31. Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars.
Luukkonen PK; Sädevirta S; Zhou Y; Kayser B; Ali A; Ahonen L; Lallukka S; Pelloux V; Gaggini M; Jian C; Hakkarainen A; Lundbom N; Gylling H; Salonen A; Orešič M; Hyötyläinen T; Orho-Melander M; Rissanen A; Gastaldelli A; Clément K; Hodson L; Yki-Järvinen H
Diabetes Care; 2018 Aug; 41(8):1732-1739. PubMed ID: 29844096
[TBL] [Abstract][Full Text] [Related]
32. Investigating dual inhibition of ACC and CD36 for the treatment of nonalcoholic fatty liver disease in mice.
Devereux CJ; Bayliss J; Keenan SN; Montgomery MK; Watt MJ
Am J Physiol Endocrinol Metab; 2023 Feb; 324(2):E187-E198. PubMed ID: 36629823
[TBL] [Abstract][Full Text] [Related]
33. Dietary carbohydrates and fats in nonalcoholic fatty liver disease.
Yki-Järvinen H; Luukkonen PK; Hodson L; Moore JB
Nat Rev Gastroenterol Hepatol; 2021 Nov; 18(11):770-786. PubMed ID: 34257427
[TBL] [Abstract][Full Text] [Related]
34. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
Fu D; Cui H; Zhang Y
Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
[TBL] [Abstract][Full Text] [Related]
35. Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice.
Fuchs CD; Claudel T; Kumari P; Haemmerle G; Pollheimer MJ; Stojakovic T; Scharnagl H; Halilbasic E; Gumhold J; Silbert D; Koefeler H; Trauner M
Hepatology; 2012 Jul; 56(1):270-80. PubMed ID: 22271167
[TBL] [Abstract][Full Text] [Related]
36. Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study.
Hodson L; Bhatia L; Scorletti E; Smith DE; Jackson NC; Shojaee-Moradie F; Umpleby M; Calder PC; Byrne CD
Eur J Clin Nutr; 2017 Aug; 71(8):973-979. PubMed ID: 28294174
[TBL] [Abstract][Full Text] [Related]
37. Optimizing human hepatocyte models for metabolic phenotype and function: effects of treatment with dimethyl sulfoxide (DMSO).
Nikolaou N; Green CJ; Gunn PJ; Hodson L; Tomlinson JW
Physiol Rep; 2016 Nov; 4(21):. PubMed ID: 27803313
[TBL] [Abstract][Full Text] [Related]
38. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
[TBL] [Abstract][Full Text] [Related]
39. Intrahepatic insulin exposure, intrahepatocellular lipid and regional body fat in nonalcoholic fatty liver disease.
Mehta SR; Godsland IF; Thomas EL; Pavitt DV; Morin SX; Bell JD; Taylor-Robinson SD; Johnston DG
J Clin Endocrinol Metab; 2012 Jun; 97(6):2151-9. PubMed ID: 22442265
[TBL] [Abstract][Full Text] [Related]
40. Out of the frying pan: dietary saturated fat influences nonalcoholic fatty liver disease.
Parks E; Yki-Järvinen H; Hawkins M
J Clin Invest; 2017 Feb; 127(2):454-456. PubMed ID: 28112684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
